Romidepsin is a histone deacetylase (HDAC) inhibitor exhibiting anti-tumor activity. It targets HDAC1, HDAC2, HDAC4, and HDAC6. This compound is utilized in PROTAC development for its ability to inhibit HDACs and facilitate targeted protein degradation. Reagent-grade; for laboratory research purposes only.
Usually ships within 24 hours.